Antibodies to PrPC block the generation of PrPScin vitro and extensive investigations have demonstrated that vaccines which induce PrPC reactive antibodies can delay, to varying degrees, the onset of prion disease symptoms (46–49). This evidence concerns the gene PRNP and prion disease.